The content of this page is intended for healthcare professionals only.

Are you a professional?

You are now visiting Wellspect global website. To view the North American website please click here click here


Why should I choose LoFric?

LoFric® catheters have been on the market for more than 30 years, offering a painless therapy and improved quality of life for users who rely on intermittent catheterization to safely empty their bladder. Today, the LoFric family of products has expanded to offer solutions which meet the needs of a wide range of users.

LoFric is the only catheter with Urotonic™ Surface Technology, ensuring our catheters are just as slippery during insertion and withdrawal. This helps minimize complications and trauma to the urethra.

Additionally, all LoFric products are manufactured without natural rubber latex, PVC or phthalates.

With over 30 years’ worth of clinical evidence, LoFric users can rest easy knowing that their catheters have been proven to effectively reduce the risk of long-term complications, such as urethral strictures and UTIs. Additionally, all LoFric products are latex-free, PVC-free, and phthalate-free making it safe and comfortable to use.

Behind LoFric, you will find a dedicated team of people who believe in what we do and are committed to making a real difference in the lives of our users. We are well known by for our expertise and commitment to urological products, our services and support.

why should i choose lofric list of statistics full width statistics

LoFric reduces the risk of both pain and damage...

LoFric catheters are coated with our unique Urotonic™ Surface Technology, which means that LoFric’s surface has the same properties as your urethra – the salt concentration is the same as in urine. This ensures that the catheter remains smooth, comfortable and safe, both during insertion and withdrawal.

...and it is scientifically proven

LoFric are the only catheters proven in multiple studies to be safe for long-term use.

1. 7 years follow up of 30 LoFric patients. Waller et al. J Urol 1995;153:345-8 2. Survey in 288 long-term (10 years) LoFric users. Hakansson et al. Urol Nurs. 2015;35:239-47  3. Meta-analysis of 464 patients. Li et al. Arch Phys Med Rehabil. 2013;94:782-7